Near-infrared (NIR) light-induced imaging-guided
cancer therapy has been studied extensively in recent years. Herein, we report a novel
theranostic nanoplatform by modifying
polyoxometalate (POM) nanoclusters onto mesoporous
silica-coated upconversion nanoparticles (UCNPs), followed by loading
doxorubicin (DOX) in the mesopores and coating a
folate-
chitosan shell onto the surface. In this nanoplatform, the core-shell structured UCNPs (NaYF4:Yb,Er@NaYF4:Yb,Nd) showed special upconverting luminescence (UCL) when irradiated with high-penetration 808 nm NIR light, and the doped Yb and Nd
ions endowed the sample with CT imaging properties, thus achieving a dual-mode imaging function. Moreover, the simultaneously generated heat mediated by the 808 nm NIR light may coordinate with the
chemotherapy generated from the released DOX to realize an efficient synergistic
therapy, verified by diverse in vitro and in vivo assays. The coated
folate-
chitosan shell can target the platform to
tumor tissues when it was transported in the blood vessels and accumulated in
tumor sites via the enhanced permeability and retention effect (EPR). Due to the acidic and reductive microenvironment of the
tumor, the DOX released quickly with the dissolved
folate-
chitosan shell, exhibiting obvious tumor microenvironment (TME) responsive properties. The smart imaging-guided therapeutic nanoplatform should be highly promising in TME responsive
therapy.